Most people are familiar with brands like Pfizer, Moderna, and Johnson & Johnson when it comes to COVID-19 vaccines. However, Novavax, a business that created a COVID-19 vaccine based on proteins, is another participant in the vaccine market. You may be astonished to discover that Nuvaxovid is just another name for the Novavax vaccine as you may have heard.
What Is Novavax?
Novavax, Inc. is a biotechnology company based in the United States. Unlike mRNA vaccines (like Pfizer and Moderna), Novavax’s COVID-19 vaccine is protein subunit-based. This means it uses a lab-made version of the spike protein found on the surface of the coronavirus, along with an adjuvant to boost the immune response.
So, What Is Nuvaxovid?
Nuvaxovid is the brand name for the Novavax COVID-19 vaccine. This name is used in many countries, including those in the European Union, Canada, and Australia. In the United States, the vaccine was initially referred to simply as the “Novavax COVID-19 Vaccine, Adjuvanted” when it received emergency use authorization. However, it is now also marketed under the Nuvaxovid name globally.
Why the Different Names?
It’s common for vaccines and medications to have both a company/development name and a brand name. For example, the Pfizer-BioNTech vaccine is branded as Comirnaty, and Moderna’s vaccine is branded as Spikevax. These brand names are approved by regulatory agencies and help standardize naming across international markets.